329 related articles for article (PubMed ID: 25612181)
1. Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection.
Kamitsukasa H; Iri M; Tanaka A; Nagashima S; Takahashi M; Nishizawa T; Okamoto H
J Med Virol; 2015 Apr; 87(4):589-600. PubMed ID: 25612181
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient.
Feeney SA; McCaughey C; Watt AP; Agnaf MR; McDougall N; Wend UC; Gerlich WH; Coyle PV
J Med Virol; 2013 Apr; 85(4):597-601. PubMed ID: 23359331
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
[TBL] [Abstract][Full Text] [Related]
4. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
Borentain P; Colson P; Coso D; Bories E; Charbonnier A; Stoppa AM; Auran T; Loundou A; Motte A; Ressiot E; Norguet E; Chabannon C; Bouabdallah R; Tamalet C; Gérolami R
J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
[TBL] [Abstract][Full Text] [Related]
5. Reactivation from occult HBV carrier status is characterized by low genetic heterogeneity with the wild-type or G1896A variant prevalence.
Inuzuka T; Ueda Y; Morimura H; Fujii Y; Umeda M; Kou T; Osaki Y; Uemoto S; Chiba T; Marusawa H
J Hepatol; 2014 Sep; 61(3):492-501. PubMed ID: 24798622
[TBL] [Abstract][Full Text] [Related]
6. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
Datta S; Banerjee A; Chandra PK; Chowdhury A; Chakravarty R
J Med Virol; 2006 Jan; 78(1):53-9. PubMed ID: 16299727
[TBL] [Abstract][Full Text] [Related]
7. Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland.
Grabarczyk P; Garmiri P; Liszewski G; Doucet D; Sulkowska E; Brojer E; Allain JP;
J Viral Hepat; 2010 Jun; 17(6):444-52. PubMed ID: 19780948
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient.
Awerkiew S; Däumer M; Reiser M; Wend UC; Pfister H; Kaiser R; Willems WR; Gerlich WH
J Clin Virol; 2007 Jan; 38(1):83-6. PubMed ID: 17134939
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection with positive hepatitis B e antigen.
Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
[TBL] [Abstract][Full Text] [Related]
12. Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT.
Viganò M; Vener C; Lampertico P; Annaloro C; Pichoud C; Zoulim F; Facchetti F; Poli F; Scalamogna M; Deliliers GL; Colombo M
Bone Marrow Transplant; 2011 Jan; 46(1):125-31. PubMed ID: 20383209
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers.
Chen GD; Gu JL; Qiu J; Chen LZ
Transpl Infect Dis; 2013 Jun; 15(3):300-5. PubMed ID: 23473005
[TBL] [Abstract][Full Text] [Related]
14. Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection.
Kanaan N; Kabamba B; Maréchal C; Pirson Y; Beguin C; Goffin E; Hassoun Z
J Clin Virol; 2012 Nov; 55(3):233-8. PubMed ID: 22921412
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
16. Appearance of HbeAg in an occult persistent hepatitis B virus infection.
Paparella C; De Rosa F; Longo R; Cappiello G; Ursitti A; Rosa M; Morosetti M; Spanò A
Intervirology; 2010; 53(3):173-5. PubMed ID: 20130415
[TBL] [Abstract][Full Text] [Related]
17. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ
J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955
[TBL] [Abstract][Full Text] [Related]
19. The difficulties of managing severe hepatitis B virus reactivation.
Roche B; Samuel D
Liver Int; 2011 Jan; 31 Suppl 1():104-10. PubMed ID: 21205146
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the interspousal transmission of hepatitis B virus in two Japanese patients who acquired fulminant hepatitis B after 50 and 49 years of marriage.
Okamoto D; Nakayama H; Ikeda T; Ikeya S; Nagashima S; Takahashi M; Sugai Y; Okamoto H
J Med Virol; 2014 Nov; 86(11):1851-60. PubMed ID: 25132075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
